Articles

A quick look at the current statistics sends an alarming message: The state of cardiovascular health in the United States is abysmal. With diabetes and obesity on the rise, we as physicians need...

Early defibrillation is often referred to as the “critical link in the chain of survival,” according to the American Heart Association (AHA). But even in a hospital setting, the time from when a...

Atherectomy is a key treatment option in peripheral artery disease (PAD), and several physicians Diagnostic & Invasive Cardiology recently spoke with are fans of the laser over...

New U.S. Food and Drug Administration (FDA) indications for two key heart failure device therapies may help improve survival, slow the progress of the disease and, in some cases, reverse its...

There were many unique technologies showcased at the recent American College of Cardiology (ACC) 2010 Scientific Sessions, which may impact the practice of cardiology in the near future.

...

As intravascular ultrasound (IVUS) becomes a more common tool in cath labs to assess lesions and stent treatments, new innovations loom on the horizon. These tools include forward-looking IVUS and...

Intracardiac echocardiography (ICE) offers a clearer view of transcatheter devices and electrophysiology (EP) procedures from inside the heart.

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States....

Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in...

In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD) treatments. For this reason, device...